Browsing by Author Vergote, I

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome locideFazio, Anna; Gao, Bo-Fu; Kennedy, Catherine Jane; Beckmann, M W; et al, Various; Fasching, Peter A.; Glubb, Dylan M; Johnatty, Sharon E.; Lambrechts, Diether; O'Mara, Tracy A.; Quinn, Michael C. J.; Tyrer, Johnathan; Vergote, I; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Obstetrics & GynaecologyAnalyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci, Oncotarget, vol.8, 39, 2017,pp 64670-64684
2017Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trialDavies, Lucy; Gebski, Val; Gibbs, Emma; Lee, C.; Veillard, Anne-Sophie; Bamias, A; Bloemendal, H; Dimopoulos, M; Floquet, A.; Kosse, J; Lykka, M; Mirza, Mansoor Raza; Pujade-Lauraine, Eric; santaballa, A; Tabaro, G; Vergote, I; Zagouri, F; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: Exploratory analyses of the AURELIA trial, Annals of Oncology, vol.28, 8, 2017,pp 1842-1848
2013A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancerBrown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Baumann, K; Berton-Rigaud, D; et al, Various; Parma, G.; Pfisterer, J; Pisano, C.; Plante, M.; Schauer, C; Skeie-Jensen, T; Swart, Ann Marie; Vergote, I; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreA prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer, Annals of Oncology, vol.24, 4, 2013,pp 937-943